The Conditions of Participation (CoPs) mandates that an initial and comprehensive patient assessment include a drug profile (Standard 418.54).
The drug profile should review each prescription, OTC, and herbal medication ordered for a patient.
Delta Care Rx CoPs Reports will provide you with complete medication profiles always delivered in time for your IDG team meetings. You will receive a Patient-Specific CoPs Report/Consult which can easily complete the drug profile section of the CMS required comprehensive patient assessment.
The CoPs Report, along with all Deltalytics Reports, can be accessed via our e-Tools suite or sent to you via secure email/FTP.
"Condition of participation: Initial and comprehensive assessment of the patient," Title 42 Code of Federal Regulation, Pt 418.54. 2008 ed